Joseph Monahan
2021
In 2021, Joseph Monahan earned a total compensation of $5.3M as Chief Scientific Officer at Aclaris Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $154,700 |
|---|---|
| Salary | $350,000 |
| Stock Awards | $4,812,000 |
| Other | $10,605 |
| Total | $5,327,305 |
Monahan received $4.8M in stock awards, accounting for 90% of the total pay in 2021.
Monahan also received $154.7K in non-equity incentive plan, $350K in salary and $10.6K in other compensation.
Rankings
In 2021, Joseph Monahan's compensation ranked 2,428th out of 12,415 executives tracked by ExecPay. In other words, Monahan earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,428 out of 12,415 | 80th |
Division Manufacturing | 961 out of 5,508 | 83rd |
Major group Chemicals And Allied Products | 365 out of 2,378 | 85th |
Industry group Drugs | 317 out of 2,099 | 85th |
Industry Pharmaceutical Preparations | 208 out of 1,549 | 87th |
Source: SEC filing on April 21, 2022.
Monahan's colleagues
We found four more compensation records of executives who worked with Joseph Monahan at Aclaris Therapeutics in 2021.